◆ 会议时间：2022年9月7日至10日
◆ 会议地点：意大利 米兰

◆ 会议简介：

2022年第31届欧洲皮肤病与性病学会(EADV)大会将于2022年9月7日至10日在意大利米兰以线上线下结合形式举行。EADV大会是皮肤性病学领域最具影响力的国际会议之一，与会者将有机会聆听700多位知名演讲者的发言并与其进行交流，参与150多场有关皮肤病学和性病学最新研究与进展的学术会议。上届EADV大会（2019）有来自全球100多个国家的12000余名代表参会。

欧洲皮肤病与性病学会(EADV)是成立于1987年的一个非营利医学学会，致力于推进皮肤性病学领域的教育、研究与培训的发展。EADV的愿景是成为欧洲首屈一指的皮肤性病学会，其首要目标宣是改善和提高对患者的护理，为欧洲所有的皮肤性病学家提供相关的继续医学教育等。EADV每年在欧洲国家举办一次大会和一次春季会议。未经许可禁止复制摘录转载本站任何内容-领域国际医学会议网(lingyuint.com).

EADV 2022 - 31st Congress of the European Academy of Dermatology and Venereology（EADV）
Dates: 7-11 September 2022
Venue: Milano, Italy

DESIGNING THE FUTURE OF DERMATOLOGY AND VENEREOLOGY

摘要征集：

• Abstracts submission opens：  8 February 2022
• Abstracts submission closes： 26 April 2022
• Abstracts evaluation notification： 21 June 2022
• Late Abstract Submission Opening: 14 July 2022
• Late Abstract Submission Deadline: 28 July 2022
• Late Abstract Evaluation Deadline: 9 August 2022

点此提交摘要>>>Submit Abstract>>>

Abstracts must be submitted in English. A “blind” selection process will be used. No identifying features such as names of hospitals, medical schools, clinics or cities may be listed in the title or text of the abstract. Do not include the names of authors either. Their names and affiliations (institutions) will be registered separately when submitting the abstract online. There is no limit for the number of authors that can be included in one abstract.
There is no limit for the number of abstracts that one author can submit either.

The title should not be written entirely in capital letters (e.g. NOT LIKE THIS).

The size of the abstract is limited to 3,000 characters. The submission program will automatically calculate the size of your abstract and will not allow submissions that do not fit in the size requirements.
Figures and tables are allowed and they are not taken into consideration in the word count.
Abstract title and authors’s names and affiliations are not included in the word count neither, since they are specified in different steps of the abstract submission and do not need to be included in the abstract body. 
On the other hand, headings (Introduction, Material and methods, Results, Discussion) count towards the 3’000-character limit.

The template of the abstract is structured with the following subheadings:

1. Introduction
2. Materials and Methods
3. Results
4. Discussion

If your abstract describes a case report, you can insert the whole text under the “Results” section.

Encore abstracts are allowed.

Check spelling and grammar carefully. Direct reproduction from your electronically submitted abstract text means that any errors in spelling, grammar or scientific data will be reproduced as submitted.

Use generic names. The use of commercial drug names, brands and registered trademarks are strictly prohibited. Drugs should be referred to by the active substance or pharmacological designation.
No mention of pharmaceutical company names should be included in the abstract either.

The evaluation and scoring of the abstract (acceptance as poster or as oral communication, or rejection) will be made according to a number of criteria, including:

• Is the content interesting, informative, novel or important?
• Are the methods valid, the results relevant and the conclusions justified by the data?
• Is the data presented with clarity and in an appropriate structure?
• Is the text well written in English with a clear syntactic style?

The authors should specify if they prefer their submission to be considered for:

• e-Poster presentation only
• Oral presentation only
• Indifferent

LATE BREAKING ABSTRACTS

The Scientific Committee invites authors of very important results to submit their late breaking abstracts for consideration and inclusion in the “Late breaking news” sessions that will take place during the EADV congress.

Abstracts may be submitted by authors or submitters having obtained all rights from authors to proceed with the submission.

Please note that the submission of each late abstract has an administrative cost of 100€. The submission process is concluded with your payment of said amount to the EADV. Authors of rejected, incomplete or wrongly submitted abstracts will not be refunded and will not benefit from an oral presentation during the congress.

The EADV Scientific Programming Committee will review all abstracts one by one and select the best ones (for a predetermined number of slots). The authors of such abstracts are invited to hold a 15 minute presentation (10+3 of Q&A) during the “Late breaking news” sessions.

The other abstracts will be rejected and will not benefit from an oral presentation during the congress.

注册费：

FULL REGISTRATION

Full Ticket includes access to the following:

• Congress Scientific Sessions 
• Networking Symposium on Wednesday, 7 September 2022
• Subspecialty Society Meetings on Wednesday, 7 September 2022
• e-poster area, EADV Hall and Patient Advocacy Booth
• Exhibition Hall (for Healthcare Professionals and Industry Participants only)
• Satellite Symposia Sessions and Industry Hub sessions *
• Transportation Pass

• EADV Virtual Congress Platform during the event and up until 30 November 2022, including access to the following:
• streaming of Subspecialty Society Meetings (Wednesday, 7 September 2022)
• online library of e-posters and abstracts
• EADV profile and Patient Advocacy Booth 
• Exhibiting company profiles (for Healthcare Professionals and Industry Participants only)
• Live streaming of selected Satellite Symposia Sessions*

As well as eligibility to claim ECMEC Credits on participation in the live Scientific Sessions you can also claim ECMEC Credits on participation in the on-demand Scientific Sessions up until 30 November.

* IMPORTANT: Industry Session organisers could limit participation to certain representative groups independently from EADV recommendations if deemed imperative to the achievement of the intended purpose of the Industry session. The organising company reserved the right to refuse single categories, in particular if not adequately related to the objective and purpose of the session.

VIRTUAL REGISTRATION

Virtual Ticket includes access to the following:

• EADV Virtual Congress Platform during the event and until 30 November 2022
• streaming of Subspecialty Society Meetings (Wednesday, 7 September 2022)
• online library of e-posters and abstracts
• EADV profile and Patient Advocacy Booth 
• Exhibiting company profiles (for Healthcare Professionals and Industry Participants only)
• Live streaming of selected Satellite Symposia Sessions*
• Eligibility to claim ECMEC Credits on participation in the live-streamed Scientific Sessions

* IMPORTANT: Industry Session organisers could limit participation to certain representative groups independently from EADV recommendations if deemed imperative to the achievement of the intended purpose of the Industry session. The organising company reserved the right to refuse single categories, in particular if not adequately related to the objective and purpose of the session.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。